Published in Schizophr Res on October 28, 2009
Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology (2011) 1.07
Genetic models of sensorimotor gating: relevance to neuropsychiatric disorders. Curr Top Behav Neurosci (2012) 0.97
Deficient prepulse inhibition in schizophrenia detected by the multi-site COGS. Schizophr Res (2014) 0.94
Reduced prepulse inhibition in adolescents at risk for psychosis: a 2-year follow-up study. J Psychiatry Neurosci (2011) 0.87
Reduced Prepulse Inhibition as a Biomarker of Schizophrenia. Front Behav Neurosci (2016) 0.75
Cannabidiol, among Other Cannabinoid Drugs, Modulates Prepulse Inhibition of Startle in the SHR Animal Model: Implications for Schizophrenia Pharmacotherapy. Front Pharmacol (2016) 0.75
Predictors of smoking reduction outcomes in a sample of 287 patients with schizophrenia spectrum disorders. Eur Arch Psychiatry Clin Neurosci (2015) 0.75
Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling. J Neurosci (2002) 1.61
Therapeutic action of cannabinoids in a murine model of multiple sclerosis. J Neurosci (2003) 1.47
Spatial learning deficit in transgenic mice that conditionally over-express GSK-3beta in the brain but do not form tau filaments. J Neurochem (2002) 1.42
History of the discovery and clinical introduction of chlorpromazine. Ann Clin Psychiatry (2006) 1.31
Hypofunction of right temporoparietal cortex during emotional arousal in depression. Arch Gen Psychiatry (2008) 1.18
A historical reflection of the contributions of Cajal and Golgi to the foundations of neuroscience. Brain Res Rev (2007) 1.04
Neurobehavioral and immunological consequences of prenatal immune activation in rats. Influence of antipsychotics. Neuropsychopharmacology (2006) 1.02
Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia. Schizophr Bull (2013) 0.98
Stress-induced neuroinflammation: role of the Toll-like receptor-4 pathway. Biol Psychiatry (2012) 0.95
The anti-inflammatory prostaglandin 15d-PGJ2 and its nuclear receptor PPARgamma are decreased in schizophrenia. Schizophr Res (2011) 0.95
Psychiatry and political-institutional abuse from the historical perspective: the ethical lessons of the Nuremberg Trial on their 60th anniversary. Prog Neuropsychopharmacol Biol Psychiatry (2006) 0.94
Gender-specific COMT Val158Met polymorphism association in Spanish schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet (2010) 0.93
Toll-like 4 receptor inhibitor TAK-242 decreases neuroinflammation in rat brain frontal cortex after stress. J Neuroinflammation (2014) 0.93
Cognitive impairment is related to oxidative stress and chemokine levels in first psychotic episodes. Schizophr Res (2012) 0.92
Stress mediators regulate brain prostaglandin synthesis and peroxisome proliferator-activated receptor-gamma activation after stress in rats. Endocrinology (2007) 0.92
Role of endocannabinoid system in mental diseases. Neurotox Res (2004) 0.92
Expression of nitrotyrosine and oxidative consequences in the trabecular meshwork of patients with primary open-angle glaucoma. Invest Ophthalmol Vis Sci (2008) 0.92
Inhibition of glutamate release via recovery of ATP levels accounts for a neuroprotective effect of aspirin in rat cortical neurons exposed to oxygen-glucose deprivation. Stroke (2002) 0.90
Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study. Expert Rev Neurother (2009) 0.89
Bipolar disorder as an emerging pathology in the scientific literature: a bibliometric approach. J Affect Disord (2006) 0.87
Bibliometric analysis of biomedical publications on SSRI during 1980-2000. Depress Anxiety (2003) 0.86
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study. Schizophr Res (2012) 0.85
Differential dorsolateral prefrontal cortex activation during a verbal n-back task according to sensory modality. Behav Brain Res (2009) 0.85
[Psychometric performance of the 6th version of the Addiction Severity Index in Spanish (ASI-6)]. Psicothema (2010) 0.85
Cannabinoid/agonist WIN 55,212-2 reduces cardiac ischaemia–reperfusion injury in Zucker diabetic fatty rats: role of CB2 receptors and iNOS/eNOS. Diabetes Metab Res Rev (2011) 0.84
Dosing and switching of paliperidone ER in patients with schizophrenia: recommendations for clinical practice. Ann Gen Psychiatry (2014) 0.84
Half a century since the clinical introduction of chlorpromazine and the birth of modern psychopharmacology. Prog Neuropsychopharmacol Biol Psychiatry (2004) 0.84
The effects of topiramate adjunctive treatment added to antidepressants in patients with resistant obsessive-compulsive disorder. J Clin Psychopharmacol (2006) 0.84
Cannabinoid system and neuroinflammation: implications for multiple sclerosis. Neuroimmunomodulation (2007) 0.83
Anandamide inhibits Theiler's virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB(1) receptors. J Neuroinflammation (2011) 0.83
A five-year follow-up study of neurocognitive functioning in bipolar disorder. Bipolar Disord (2014) 0.83
Children of alcoholics in Spain: from risk to pathology. Results from the ALFIL program. Soc Psychiatry Psychiatr Epidemiol (2007) 0.83
Sexually dimorphic interaction between the DRD1 and COMT genes in schizophrenia. Am J Med Genet B Neuropsychiatr Genet (2010) 0.83
Depressive-like states heighten the aversion to painful stimuli in a rat model of comorbid chronic pain and depression. Anesthesiology (2012) 0.83
Plasma antioxidant capacity is reduced in Asperger syndrome. J Psychiatr Res (2012) 0.83
Altered immune function in unaffected first-degree biological relatives of schizophrenia patients. Psychiatry Res (2012) 0.82
Management of depression in primary care: a survey of general practitioners in Spain. Gen Hosp Psychiatry (2005) 0.82
Association in alcoholic patients between psychopathic traits and the additive effect of allelic forms of the CNR1 and FAAH endocannabinoid genes, and the 3' region of the DRD2 gene. Neurotox Res (2007) 0.82
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation. Glia (2012) 0.82
The endocannabinoid anandamide from immunomodulation to neuroprotection. Implications for multiple sclerosis. Vitam Horm (2009) 0.81
[Dual diagnosis in psychiatric inpatients: prevalence and general characteristics]. Invest Clin (2008) 0.81
Immature rat brain slices exposed to oxygen-glucose deprivation as an in vitro model of neonatal hypoxic-ischemic encephalopathy. J Neurosci Methods (2005) 0.81
Trends in scientific literature on atypical antipsychotics in South Korea: a bibliometric study. Psychiatry Investig (2013) 0.81
Negative symptoms and executive function in schizophrenia: does their relationship change with illness duration? Psychopathology (2012) 0.81
The role of cannabinoid system on immune modulation: therapeutic implications on CNS inflammation. Mini Rev Med Chem (2005) 0.81
(AAT)n repeat in the cannabinoid receptor gene, CNR1: association with schizophrenia in a Spanish population. Eur Arch Psychiatry Clin Neurosci (2006) 0.81
Peripheral endocannabinoid system dysregulation in first-episode psychosis. Neuropsychopharmacology (2013) 0.81
Maintenance of attention and pathological gambling. Psychol Addict Behav (2013) 0.81
Transfer of Function to a Specific Area of the Cortex After Induced Recovery from Brain Damage. Eur J Neurosci (1992) 0.80
The role of psychopharmacology in the medical abuses of the Third Reich: from euthanasia programmes to human experimentation. Brain Res Bull (2008) 0.80
Dopamine partial agonism in antipsychotic-induced sexual dysfunction. Actas Esp Psiquiatr (2013) 0.80
Differences between early-onset pathological gambling and later-onset pathological gambling: data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Addiction (2014) 0.79
The Australian contribution to the literature on atypical antipsychotic drugs: a bibliometric study. Australas Psychiatry (2013) 0.79
Coping strategies and quality of life among liver transplantation candidates. Psicothema (2011) 0.79
Effects of naltrexone plus topiramate on ethanol self-administration and tyrosine hydroxylase gene expression changes. Addict Biol (2013) 0.79
A bibliometric study of scientific research conducted on second-generation antipsychotic drugs in Singapore. Singapore Med J (2014) 0.79
Executive function in schizophrenia: influence of substance use disorder history. Schizophr Res (2009) 0.79
Cloninger's typology and treatment outcome in alcohol-dependent subjects during pharmacotherapy with naltrexone. Addict Biol (2007) 0.79
Variables involved in the cue modulation of the startle reflex in alcohol-dependent patients. Addict Biol (2011) 0.78
Postnatal changes in the nitric oxide system of the rat cerebral cortex after hypoxia during delivery. Brain Res Dev Brain Res (2003) 0.77
Alcohol craving scale based on three factors. Eur Addict Res (2009) 0.77
Priapism associated with zuclopenthixol. Ann Pharmacother (2002) 0.77
Impairments of prepulse inhibition of the startle response in abstinent alcoholic male patients. Alcohol Alcohol (2012) 0.77
[Prepulse inhibition of the startle response/reflex in neuropsychiatric disorders]. Rev Neurol (2011) 0.77
Cognition and the five-factor model of the positive and negative syndrome scale in schizophrenia. Schizophr Res (2012) 0.77
Psychiatric comorbidity and plasma levels of 2-acyl-glycerols in outpatient treatment alcohol users. Analysis of gender differences. Adicciones (2016) 0.76
Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis. Compr Psychiatry (2012) 0.76
Naltrexone for alcohol dependence. N Engl J Med (2002) 0.76
[Cognitive deficit in schizophrenia: MATRICS Consensus Cognitive Battery]. Rev Neurol (2012) 0.76
Stress Increases the Negative Effects of Chronic Pain on Hippocampal Neurogenesis. Anesth Analg (2015) 0.76
Sensory Gating Deficits in First-Episode Psychosis: Evidence From Neurophysiology, Psychophysiology, and Neuropsychology. J Nerv Ment Dis (2016) 0.76
Is it possible to combine different psychotic symptom scales in bipolar disorder? Psychiatry Res (2014) 0.76
Mapping the scientific research on atypical antipsychotic drugs in Spain: a bibliometric assessment. Actas Esp Psiquiatr (2013) 0.76
Many people show poor adherence to their initial antipsychotic after first hospitalisation with schizophrenia. Evid Based Ment Health (2011) 0.75
Reboxetine addition in patients with mirtazapine-resistant depression: a case series. Clin Neuropharmacol (2006) 0.75
Antioxidant defense system and family environment in adolescents with family history of psychosis. BMC Psychiatry (2012) 0.75
Maintenance Electroconvulsive Therapy: Cost-effectiveness and Patient/Family Satisfaction. J ECT (2015) 0.75
[Differential effects of dual tasks on emotional processing in non-medicated patients with Parkinson's disease]. Rev Neurol (2011) 0.75
Immediate clinical assessment of medical intervention in schizophrenic patients admitted to an acute-care psychiatric unit: a retrospective, naturalistic and multicenter study. Int J Psychiatry Clin Pract (2011) 0.75
Factor structure and psychometric properties of the TFEQ in morbid obese patients, candidates to bariatric surgery. Psicothema (2015) 0.75
Double-blind, placebo-controlled study of the efficacy of reboxetine and citalopram as adjuncts to atypical antipsychotics for negative symptoms of schizophrenia. J Clin Psychiatry (2014) 0.75
The neurobiological interpretation of the mental functions in the work of Santiago Ramón y Cajal. Hist Psychiatry (2008) 0.75
Patients with alcohol use disorder: initial results from a prospective multicenter registry in the Spanish Network on Addiction Disorders. CohRTA Study. Adicciones (2017) 0.75
Cannabis abuse effects on prepulse inhibition in patients with first episode psychosis in schizophrenia. J Neuropsychiatry Clin Neurosci (2015) 0.75
Inflammatory activation and cholinergic anti-inflammatory system in eating disorders. Brain Behav Immun (2013) 0.75
[COMT Val158Met polymorphism and schizophrenia in a series of Spanish patients]. Med Clin (Barc) (2007) 0.75
[Psychosis due to vitamin B12 deficiency in an elderly patient]. Rev Neurol (2014) 0.75
Sadness as a passion of the soul: a psychopathological consideration of the Cartesian concept of melancholy. Brain Res Bull (2011) 0.75